Neuroleptic syndrome mārere huaina ...

Ko te onge, me te wehe, ki mau hopearaa mo te ora o te whakararuraru, meinga e te horomanga o taero psychotropic, ngā neuroleptics no ki ngā rōpū o phenothiazines, thioxanthenes me butirofenonov Neuroleptic syndrome mārere. Ka taea e NMS whakapataritari i te whakamahi o taputapu pērā i amphetamine, "Amoksalin" "fluoxetine", "desipramine", "phenelzine" kukarou ranei "metoclopramide".

take

āhuatanga tūponotanga hanga syndrome neuroleptic kia:

• whakahaere o te raau taero roa te rongo;
• whakamahi vysokopotentnyh o moni;
• tono ki te NMS matou nga taero tahi me taero anticholinergic;
• pōuritanga;
• pāmahana rangi;
• maimoatanga Electroconvulsive me haumākū tiketike.

Whakahōhā o mate e taea meinga take e tika ana ki te whaiaroaro pai-oranga o te manawanui. Ki te hunga ngā:

• maroketanga;
• whakamātau tinana whakaongaonga;
• waipiro;
• pōhauhautanga ;
• te wā e kulukia;
• mate intercurrent;
• kore o te rino;
• rohirohi tinana;
• whara roro pāmamae;
• pōrearea thyroid.

State o ta'e, ruhiruhia, manukanuka aronganui, tane - tāpiri hoki tenei katoa ki syndrome mārere neuroleptic. Ka taea e ZNR tohu e tino rerekē - i iti ki sino.

momo Easy o

Neuroleptic syndrome mārere āhuatanga e whai tohu: e whakatika pāmahana ki te subfebrile puta somatovegetativnye hapa iti (te pēhanga pini toto i roto i te 150 / 90-110 / 70 mm HG, tachycardia - ki runga ki te 100 kapakapa ki te meneti ..) I tua atu abnormalities i roto i te taiwhanga raraunga (nui haere ESR ki te 18-30 mm / h, te maha iti o lymphocytes - i 15 ki te 19%). No disorders o homeostasis me tupu hemodynamic. i hanga āhua Psychopathological te whakaeke te haavareraa oneiric-catatonic pängia ranei.

Ko te tohu toharite o

Ko te take i te tangata e mate ana syndrome mārere neuroleptic āhua, tohua e te tohu e whai ake nei:

• whakaaturia somatovegetativnye disorders (huangō ki tachycardia ki 120 kapakapa ki te meneti);
• kirika (38-39 nekehanga);
• tino huringa i roto i te raraunga taiwhanga (faarahi ESR ki te 35-50 mm / h, me te leukocytosis - ake 10J109 / l, heke te rahinga o leukocytes ki 10-15%);
• nui haere ngā taumata creatine phosphokinase me tranzaminaza toto;
• whakakitea te tano hypokalemia me hypovolemia.

disorders Psychopathological āhuatanga e te ahua o mana'o amentivnopodobnoy me tohu oneiric. whakakitea tohu Catatonic immobility negativism, nui haere auau (i roto i te ahiahi) take o ritenga pau te, kaupapa me te stereotype kupu.

tukanga matatini

I runga i te whakamārama o te tūāhuruiti kia puta syndrome mārere neuroleptic. Tohu o atu nui kua, ara:

• rahunga somatovegetativnye rahi roa'tu, (. dyspnea ki 30 te whakahā ia 1 meneti, tae tachycardia 120-140 kapakapa ki te meneti);
• whakanui i te wai me te kawehiko disorders;
• nui haere raruraru hemodynamic.

Ko te mea nui rawa ngā āhuatanga huringa kitea i roto i tau taiwhanga. faarahi ESR ki 40-70 mm Leucocytes / h - ake 12J109 / l, heke te maha o lymphocytes ki 3-10%, tino whakanuia ana te tohu o te creatine, alanine me te asparagine transaminase i roto i te toto. Puputu'u 'i te hinengaro e taea tae ake comatose, a soporous takahanga amential. Hiamoe, negativism, ritenga papû, lethargy, ki te hekenga i roto i reo uaua, me te, i roto i te wā tino taumaha, me immobility tino ki areflexia - syndrome mārere neuroleptic katoa.

maimoatanga

te tāututanga wawe o te mate ko te wāhi matua. Ko te take i te tangata kino syndrome mārere neuroleptic kia tohu mānukanuka uaua, tachycardia, kirika, takawhita, he sweating kitea i muri i te fariiraa i neuroleptics, dysphagia.

Ko te mea tuatahi i koe ki te mahi i te tākuta, na whakakorengia reira neuroleptics me ētahi atu taero neurotoxic. rapu hoki ngā tukanga tautoko ki te kawe ki raro, te pāmahana, me te hanga ake mo te kore o te inu. Me kingi nehe kawehiko i roto. E hiahiatia ana ki te kawe i roto i te aroturuki tupato o mahi faufaa romahā, e taea te whakakahore ano te mahi o nei ina hanga rigidity uaua nui me te ravea ore ki expectorate secretion arahau.

Me koe ki āta aroturuki mahi tākihi. Heoi, i reira he kahore taunakitanga e whakatere te wehenga osmotic ora i NMS, noa e taea āwhina reira te tautoko o te mahi tākihi. Kei te maha hiahiatia te reira ki te whakaputa i te therapy i roto i te maimoatanga tautuhinga whakarei.

rongoā

Whāki neuroleptic rongoā syndrome mārere he minaminatia i roto i te wā matatini. Hoki tenei whakaaro, relaxants uaua ( "Dantrolene") ranei agonists dopamine ( "Amantadine" me "bromocriptine"). heke te tahuti nei i roto i te whakamahi o ngā momo e rua o taero. Werohanga rerekē noa, engari mo te e whakaahuatia "Bromocriptine" tikanga i roto i te puna i roto i te moni i 2.5 ki te 5 mg 3 ngā wā-waha i te ra.

agonists dopamine, ngā i roto i nui wahi, kia tīmata āhotea ruaki ranei, a ka he taea ki te tino pōhara kē te āhua o te hauora o te syndrome mārere neuroleptic manawanui. Direct relaxant uaua whakakapi whakamahia ki pota o 10 mg / kg. Taumu'a o tona whakamahi - te whakaiti i uaua rigidity, me te te pākia o uaua kōhiwi, he hua i te mea tetahi wahi haepapa mō te tūāhuruiti. "Dantrolene" faikehekehe hepatotoxicity kia whakapataritari kakā me tae noa te mate e tika ana ki te kore ate. Na ka reira ka kia kore take ki te haere tonu ki te hamani syndrome mārere neuroleptic.

NMS whakakorea ano e te huinga o te dopamine me "dantrolene" agonists. taero Anticholinergic e whakamahia whānuitia mo te maimoatanga o te pseudoparkinsonism meinga e taero ähotea, e kore whakarato hua nui, ano, i taea e atu whakapōrearea i thermoregulation.

He he he whakahou i runga i te pānga o "carbamazepine" e whakakitea maha tūroro i te paruparu tere o te whakaaturanga NSA. Heoi, i reira he kahore raraunga pono i runga i te whai huatanga o te whakamahi o benzodiazepines mo te maimoatanga o tenei syndrome. Heoi, ka whakapiki i te huru, kia kia enei taero whai hua ki te whakaiti i te ritenga i roto i te tūroro he syndrome mārere neuroleptic.

tūāhuruiti

Ka taea te kitea te mate āhua kotahi ia 100 tysyach rehunga whakamahi depolarizing relaxants uaua ( "Miorelaksina", "ditilina" me "listenon"), me te anesthetics inhalation i roto i waiwaro kōnakonako ( "methoxyflurane", "Ftorogana" me "Halothane") . puta tūāhuruiti i roto i te tūroro ki te susceptibility tiketike ki enei taero, i fakafekau'aki ki rahunga o te konupūmā pākia i roto i te uaua papatipu. Ko te hua ko te whānui aitua, uaua, me ētahi wā mate uaua, i hanga nei e rite ki te hua o te nui nui o te wera, te pāmahana tinana hangatonu tae 42 nekehanga. ai Neuroleptic mārere Syndrome mate i roto i 20-30% o te wā.

waka tūroro

Ki runga ki te rapunga o te tūāhuruiti nohopuku-tipu Me ki te mutu tango i te raau taero whakahuatia i runga ake. No te mea taero rongoā, e kore e whakapataritari mate, e taea te tāutuhia barbiturates "pancuronium", "Tubocurarine" me te waikura Sinks. Just kia whakamahia ratou, ki te tika, te toronga o te tiaki rehunga.

No te mea rēhita i te tūponotanga o te hanganga o te ventricular fibrillation te prophylactic "Phenobarbital" me "Procainamide" toketaá haumanu. Ko reira tika hoki ki te faaineine i te tikanga meangiti, whakatakoto i runga i nui ipu oko toto ki te wai matao tio ranei. tā haerenga reira tonu te kupukupu tonu rangi, wero konutai hydrogencarbonate / i roto i (400 ml o 3% otinga). I roto i te wā mōrearea, reira tūtohutia te whakatinanatanga o te whakaora. Hohipera - Ko tenei te mea tuatahi ki te mahi, ki te pāngia syndrome mārere neuroleptic.

outlook

Reira i roto i te hītori o NSA ko faarahi tonu te tūponotanga o te kāwanatanga taua o te rere tuarua, me te akoranga uaua te ahuatanga kaha. Ano, tata kore e disorders puta i roto i tenei syndrome Karo hanganga roro, kahore he wahi, te hanga te hunga atu disorders neurological ranei. Na he aha te mea neuroleptic syndrome mārere? Ko te mate e tino impairs ora o te tangata, a tae noa e taea arahi ki te mate.